Multiplexed Diagnostics Market

Multiplexed Diagnostics Market (Technologies - Very High Density, High Density, Medium Density, Low Density, and Next Generation Sequencing Assays; Applications - Infectious Disease Diagnostics, Oncology, Autoimmune Diseases, Cardiac Diseases, and Allergies; End Users - Academic Research Institutes, Hospitals, Pharmaceuticals Companies, Clinical Research Organizations, and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • Rep Id : TMRGL1719
  • Published On : Jan 2017
  • No. of Pages : 194
  • Category : Healthcare

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology 
     2.1. Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary
     3.1. Global Multiplexed Diagnostics Market Snapshot 

4. Market Overview
     4.1. Product Overview
     4.2. Demographics & Market Indicators 
     4.3. Key Industry Events 
     4.4. Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, 2014–2024 
     4.5. Global Multiplexed Diagnostics Market Outlook 
     4.6. Porter's Five Forces Analysis

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
            5.2.1. Growing demand for automated equipment and multifaceted analytical strategies
            5.2.2. Significant private and public funding for genomics and personalized medicine
            5.2.3. Rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases
            5.2.4. Increasing prevalence of cancer and infectious diseases
            5.2.5. Favorable regulatory scenario for new product launch
            5.2.6. Multiple Application of multiplexed diagnostics technology
     5.3. Restraints
            5.3.1. High cost associated with multiplexed diagnostics assay
            5.3.2. Lack of skilled labor
            5.3.3. High cost associated with multiplexed diagnostics assay
            5.3.4. Lack of skilled labor
     5.4. Opportunities
            5.4.1. Focus on extensive R&D to expand existing multiplexed diagnostics applications
            5.4.2. Development of generic platforms for multiplexed diagnostics
     5.5. Opportunity Analysis 

6. Global Multiplexed Diagnostics Market Analysis, by Technology
     6.1. Introduction
     6.2. Key Findings
     6.3. Global Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016-2024 
            6.3.1. Very High Density Multiplexed Assays (> 10,000-plex)
            6.3.2. High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)
            6.3.3. Medium Density Multiplexed Assays (plex < 500)
            6.3.4. Low Density Multiplexed Assays (plex ≤ 5)
            6.3.5. Next Generation Sequencing Assays
     6.4. Global Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2014–2024
     6.5. Key Trends

7. Global Multiplexed Diagnostics Market Analysis, by Application
     7.1. Introduction
     7.2. Key Findings
     7.3. Global Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 -2024
            7.3.1. Infectious Disease Diagnostic
            7.3.2. Oncology
            7.3.3. Autoimmune Diseases
            7.3.4. Cardiac Diseases
            7.3.5. Allergies
            7.3.6. Others (pregnancy & fertility testing, etc.)
     7.4. Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2014-2024
     7.5. Key Trends

8. Global Multiplexed Diagnostics Market Analysis, by End User
     8.1. Introduction
     8.2. Key Findings
     8.3. Global Multiplexed Diagnostics Market Value Share Analysis, by End-user 2016-2024
            8.3.1. Academic Research Institutes
            8.3.2. Hospitals
            8.3.3. Pharmaceutical Companies
            8.3.4. Clinical Research Organizations
            8.3.5. Diagnostic Laboratories
     8.4. Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
     8.5. Key Trends

9. Global Multiplexed Diagnostics Market Analysis, by Region
     9.1. Global Market Scenario by Country
     9.2. Global Multiplexed Diagnostics Market Value Share Analysis, by Region, 2016 and 2024 

10. North America Multiplexed Diagnostics Market Analysis
     10.1. Key Findings
     10.2. Market Overview
     10.3. North America Multiplexed Diagnostics Market Value Share Analysis, by Country
     10.4. North America Multiplexed Diagnostics Market Value Share Analysis, by Technology 
     10.5. North America Multiplexed Diagnostics Market Value Share Analysis, by Application 
     10.6. North America Multiplexed Diagnostics Market Value Share Analysis, by End User 
     10.7. North America Multiplexed Diagnostics Market Attractiveness Analysis 
     10.8. North America Multiplexed Diagnostics Market Trends 

11. Europe Multiplexed Diagnostics Market Analysis
     11.1. Key Findings
     11.2. Market Overview
     11.3. Europe Multiplexed Diagnostics Market Value Share Analysis, by Country
     11.4. Europe Multiplexed Diagnostics Market Value Share Analysis, by Technology 
     11.5. Europe Multiplexed Diagnostics Market Value Share Analysis, by Application 
     11.6. Europe Multiplexed Diagnostics Market Value Share Analysis, by End User 
     11.7. Europe Multiplexed Diagnostics Market Attractiveness Analysis 
     11.8. Europe Multiplexed Diagnostics Market Trends 

12. Asia Pacific Multiplexed Diagnostics Market Analysis
     12.1. Key Findings
     12.2. Market Overview
     12.3. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Country
     12.4. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Technology 
     12.5. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Application 
     12.6. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by End User 
     12.7. Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis 
     12.8. Asia Pacific Multiplexed Diagnostics Market Trends 

13. Latin America Multiplexed Diagnostics Market Analysis
     13.1. Key Findings
     13.2. Market Overview
     13.3. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Country
     13.4. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Technology 
     13.5. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Application 
     13.6. Latin America Multiplexed Diagnostics Market Value Share Analysis, by End User 
     13.7. Latin America Multiplexed Diagnostics Market Attractiveness Analysis 
     13.8. Latin America Multiplexed Diagnostics Market Trends 

14. Middle East & Africa Multiplexed Diagnostics Market Analysis
     14.1. Key Findings
     14.2. Market Overview
     14.3. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Country
     14.4. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Technology 
     14.5. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Application 
     14.6. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by End User 
     14.7. Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis 
     14.8. Middle East & Africa Multiplexed Diagnostics Market Trends 

15. Competition Landscape
     15.1. Multiplexed Diagnostics Market Share Analysis By Company, 2015
     15.2. Competition Matrix
     15.3. Company Profiles
            15.3.1. Agilent Technologies
                      15.3.1.1. Company Details
                      15.3.1.2. Business Overview
                      15.3.1.3. Financial Overview
                      15.3.1.4. Strategic Overview
                      15.3.1.5. SWOT Analysis
            15.3.2. bioMérieux SA
                      15.3.2.1. Company Details
                      15.3.2.2. Business Overview
                      15.3.2.3. Financial Overview
                      15.3.2.4. Strategic Overview
                      15.3.2.5. SWOT Analysis
            15.3.3. Bio-Rad Laboratories, Inc.
                      15.3.3.1. Company Details
                      15.3.3.2. Business Overview
                      15.3.3.3. Financial Overview
                      15.3.3.4. Strategic Overview
                      15.3.3.5. SWOT Analysis
            15.3.4. Illumina, Inc.
                      15.3.4.1. Company Details
                      15.3.4.2. Business Overview
                      15.3.4.3. Financial Overview
                      15.3.4.4. Strategic Overview
                      15.3.4.5. SWOT Analysis
            15.3.5. F. Hoffmann-La Roche Ltd.
                      15.3.5.1. Company Details
                      15.3.5.2. Business Overview
                      15.3.5.3. Financial Overview
                      15.3.5.4. Strategic Overview
                      15.3.5.5. SWOT Analysis
            15.3.6. Hologic, Inc.
                      15.3.6.1. Company Details
                      15.3.6.2. Business Overview
                      15.3.6.3. Financial Overview
                      15.3.6.4. Strategic Overview
                      15.3.6.5. SWOT Analysis
            15.3.7. Luminex Corporation
                      15.3.7.1. Company Details
                      15.3.7.2. Business Overview
                      15.3.7.3. Financial Overview
                      15.3.7.4. Strategic Overview
                      15.3.7.5. SWOT Analysis
            15.3.8. Siemens Healthineers
                      15.3.8.1. Company Details
                      15.3.8.2. Business Overview
                      15.3.8.3. Financial Overview
                      15.3.8.4. Strategic Overview
                      15.3.8.5. SWOT Analysis
            15.3.9. Thermo Fisher Scientific, Inc.
                      15.3.9.1. Company Details
                      15.3.9.2. Business Overview
                      15.3.9.3. Financial Overview
                      15.3.9.4. Strategic Overview
                      15.3.9.5. SWOT Analysis
            15.3.10. Abbott Laboratories 
                      15.3.10.1. Company Details
                      15.3.10.2. Business Overview
                      15.3.10.3. Financial Overview
                      15.3.10.4. Strategic Overview
                      15.3.10.5. SWOT Analysis

List of Tables

TABLE 1 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014–2024
TABLE 2 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014–2024
TABLE 3 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014–2024
TABLE 4 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Region, 2014–2024
TABLE 5 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014–2024
TABLE 6 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014–2024
TABLE 7 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014–2024
TABLE 8 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014–2024
TABLE 9 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014–2024
TABLE 10 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014–2024
TABLE 11 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014–2024
TABLE 12 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014–2024
TABLE 13 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014–2024
TABLE 14 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014–2024
TABLE 15 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014–2024
TABLE 16 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014–2024
TABLE 17 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014–2024
TABLE 18 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014–2024
TABLE 19 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014–2024
TABLE 20 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014–2024
TABLE 21 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014–2024
TABLE 22 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014–2024
TABLE 23 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014–2024
TABLE 24 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014–2024

List of Figures

FIG. 1 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, 2014–2024
FIG. 2 Multiplexed Diagnostics Market Value Share, by Application (2016)
FIG. 3 Multiplexed Diagnostics Market Value Share, by Region (2016)
FIG. 4 Multiplexed Diagnostics Market Value Share, by Technology (2016)
FIG. 5 Multiplexed Diagnostics Market Value Share, by End-user (2016)
FIG. 6 Global Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
FIG. 7 Global Very High Density Multiplexed Assays (> 10,000-plex) Market Revenue (US$ Mn), 2014–2024
FIG. 8 Global High Density Multiplexed Assays (500 ≤ plex ≤ 10,000) Market Revenue (US$ Mn), 2014–2024
FIG. 9 Global Medium Density Multiplexed Assays (plex < 500) Market Revenue (US$ Mn), 2014–2024
FIG. 10 Global Low Density Multiplexed Assays (plex ≤ 5) Market Revenue (US$ Mn), 2014–2024
FIG. 11 Global Next Generation Sequencing Assays Market Revenue (US$ Mn), 2014–2024
FIG. 12 Multiplexed Diagnostics Market Attractiveness Analysis, by Technology , 2016–2024
FIG. 13 Global Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
FIG. 14 Global Infectious Disease Diagnostic Market Revenue (US$ Mn), 2014–2024
FIG. 15 Global Oncology Market Revenue (US$ Mn), 2014–2024
FIG. 16 Global Infectious Disease Diagnostic Market Revenue (US$ Mn), 2014–2024
FIG. 17 Global Cardiac Diseases Market Revenue (US$ Mn), 2014–2024
FIG. 18 Global Allergies Market Revenue (US$ Mn), 2014–2024
FIG. 19 Global Others Market Revenue (US$ Mn), 2014–2024
FIG. 20 Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2014–2024
FIG. 21 Global Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
FIG. 22 Global Academic Research Institutes Market Revenue (US$ Mn), 2014-2024
FIG. 23 Global Hospitals Market Revenue (US$ Mn), 2014–2024
FIG. 24 Global Pharmaceutical Companies Market Revenue (US$ Mn), 2014–2024
FIG. 25 Global Clinical Research Organizations Market Revenue (US$ Mn), 2014–2024
FIG. 26 Global Diagnostic Laboratories Market Revenue (US$ Mn), 2014–2024
FIG. 27 Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
FIG. 28 Global Multiplexed Diagnostics Market Value Share Analysis, by Region, 2016 and 2024
FIG. 29 Global Multiplexed Diagnostics Market Attractiveness Analysis, by Region, 2014–2024
FIG. 30 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG. 31 North America Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016–2024
FIG. 32 North America Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
FIG. 33 North America Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
FIG. 34 North America Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
FIG. 35 North America Multiplexed Diagnostics Market Value Share Analysis, by End User, 2016 and 2024
FIG. 36 North America Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016–2024
FIG. 37 North America Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016–2024
FIG. 38 North America Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016–2024
FIG. 39 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG. 40 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016–2024
FIG. 41 Europe Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
FIG. 42 Europe Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
FIG. 43 Europe Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
FIG. 44 Europe Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
FIG. 45 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016–2024
FIG. 46 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016–2024
FIG. 47 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016–2024
FIG. 48 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG. 49 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016–2024
FIG. 50 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
FIG. 51 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
FIG. 52 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
FIG. 53 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
FIG. 54 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016–2024
FIG. 55 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016–2024
FIG. 56 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016–2024
FIG. 57 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG. 58 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016–2024
FIG. 59 Latin America Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
FIG. 60 Latin America Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
FIG. 61 Latin America Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
FIG. 62 Latin America Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
FIG. 63 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016–2024
FIG. 64 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016–2024
FIG. 65 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016–2024
FIG. 66 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG. 67 Middle East & Africa Multiplexed Diagnostics Market  Attractiveness Analysis, by Country, 2016–2024
FIG. 68 Middle East & Africa Multiplexed Diagnostics Market  Value Share Analysis, by Country, 2016 and 2024
FIG. 69 Middle East & Africa Multiplexed Diagnostics Market  Value Share Analysis, by Technology, 2016 and 2024
FIG. 70 Middle East & Africa Multiplexed Diagnostics Market  Value Share Analysis, by Application, 2016 and 2024
FIG. 71 Middle East & Africa Multiplexed Diagnostics Market  Value Share Analysis, by End-user, 2016 and 2024
FIG. 72 Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016–2024
FIG. 73 Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016–2024
FIG. 74 Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016–2024
FIG. 75 Global Multiplexed Diagnostics Market Share Analysis, by Company, 2016 (Estimated)

.